COMMUNIQUÉS West-GlobeNewswire

Turning Point Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
22/04/2019
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq:TPTX), a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, today [...]
CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors
22/04/2019
SOUTH SAN FRANCISCO, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019
22/04/2019
PLANO, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended [...]
OrthoPediatrics Corp. Announces Licensing Partnership with CoorsTek Medical
22/04/2019
WARSAW, Ind., April 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce a [...]
Brainsway Ltd. Announces Closing of Initial Public Offering
22/04/2019
JERUSALEM, April 22, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ: BWAY and TASE: BRIN) (“Brainsway”) today announced that it has closed its initial public offering of 2,500,000 American Depositary Shares (“ADSs”), [...]
DLT Resolution Provides Shareholder Update
22/04/2019
Las Vegas, NV, April 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management, Information Technology and Telecommunications [...]
Alliqua BioMedical CEO Provides Update to Shareholders
22/04/2019
LANGHORNE, Pa., April 22, 2019 (GLOBE NEWSWIRE) -- Dear Shareholder: On January 3rd, I wrote a letter updating you, our shareholders, on the status of events that I thought would affect each of you in a positive way. [...]
Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019
22/04/2019
Company management to host a webcast and conference call to provide a business update and review financial results at 8:30 a.m. ET WALTHAM, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: [...]
Chiesi and Durham Bulls Partnership Steps up to Bat for Local Charities
22/04/2019
As the season’s presenting strikeouts sponsor, Chiesi pledges to donate to three area nonprofits CARY, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Starting today, Chiesi (key-A-zee), a Cary-based specialty pharmaceutical [...]
CohBar Announces the Appointment of David Greenwood to its Board of Directors
22/04/2019
Board expansion adds significant biotechnology operational and financial expertise MENLO PARK, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Progyny Launches Special “This is Infertility” Podcast Episodes in Honor of National Infertility Awareness Week
22/04/2019
New York City, April 22, 2019 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, announced today the launch of a special, “This is Infertility” podcast series. The four episodes are aimed to [...]
RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting
22/04/2019
NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in Vision and Ophthalmology [...]
Teligent Provides Update on Orphan Drug Complete Response Letter
22/04/2019
BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the [...]
Syneos Health Wins Best CRO Award at the Vaccine Industry Excellence Awards
22/04/2019
Award Recognizes Company’s Vaccine Expertise, Spanning End-to-End Clinical and Commercial Solutions MORRISVILLE, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated [...]
Hemispherx Biopharma Names Ellen Lintal as New Chief Accounting Officer
22/04/2019
OCALA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma, Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, today [...]
Shineco, Inc. Enters into Strategic Cooperation Frame Agreement with Shenzhen Datong Industrial Co., Ltd
22/04/2019
BEIJING, April 22, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Menlo Therapeutics to Present at the Class of 2018 Biotech IPOs Investor Day
22/04/2019
REDWOOD CITY, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology
22/04/2019
BERKELEY HEIGHTS, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer
22/04/2019
BERKELEY, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING) and A Proliferation [...]

Pages